Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of Using the CiniMacs® Device for Alpha/Best T-Cell Depletion in Stem Cell Transplant Recipients

NCT04337515 is registered in ClinicalTrials.gov with Christopher Dvorak as lead sponsor.

NCT NCT04337515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04337515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of Using the CiniMacs® Device for Alpha/Best T-Cell Depletion in Stem Cell Transplant Recipients
Lead sponsor
Christopher Dvorak
Phase
Not applicable
Overall status
Recruiting
Start date
December 19, 2019
Completion date
January 1, 2035
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft vs host disease, graft-versus-host-disease